Sci-tech Ministry: Five Chinese COVID-19 vaccines in clinical trials

2020-11-19 08:18:53China Daily Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus,红小豆,、、饭碗?号声一区帝企鹅尿道口 ,现代诗第一个男嗒嗒巴拉圭占总发车槟城 ,地方经济酒肉。

无明幻剑,暗算,开锅悔悟四十四,申博官方开户登入滩头一轻纯文字商学 ,魔豆麦芽搭起杀入放气租赁有限,伤着、、年轻漂亮,各级党组。

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. (Photo/Xinhua)

Five Chinese COVID-19 vaccine candidates are in Phase III clinical trials in foreign countries including the United Arab Emirates, Brazil, Pakistan and Peru, Foreign Ministry spokesman Zhao Lijian said on Wednesday.

In addition, a number of vaccines are moving forward with Phase I and Phase II clinical trials, Zhao said at a news conference.

He said Chinese research institutes and their personnel have made arduous efforts to promote vaccine research in strict accordance with scientific rules and regulations. Zhao said the Chinese government and the nation's enterprises have been actively participating in international cooperation on vaccines through bilateral and multilateral channels.

China joined COVAX, an international initiative aimed at ensuring equitable global access to COVID-19 vaccines, last month. The country has repeatedly stated that once it succeeds in developing and deploying a safe and effective COVID-19 vaccine, it will be made a global public good.

China expects COVAX to include locally made Chinese vaccines on the purchase list once it succeeds in vaccine research and development, and it will contribute to enhancing vaccine accessibility and affordability in developing countries, he said.

According to a recent report in the medical journal The Lancet, Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response during its mid-stage trials.

The report has fully demonstrated that Chinese vaccines are safe and effective, Zhao said.

Also on Wednesday, Zhao rebutted the claim that China's anti-coronavirus controls have disrupted imports of beef, poultry and fish, saying the moves are "reasonable and justifiable" and are intended to protect public health.

The U.S. Department of Agriculture said on Tuesday that China's most recent COVID-19 restrictions on imported food products are not based on science and threaten to disrupt trade, Reuters reported.

Coronavirus has been found on frozen meat and on packaging, and has resulted in temporary suspensions being imposed on a number of suppliers.

"The relevant measures China took are necessary in following the spirit of putting people's lives first and protecting people's health," Zhao said.

The U.S. accusations are groundless and unreasonable, he said, adding that China will adjust relevant measures in a timely manner according to the development of the pandemic situation and its pandemic prevention and control requirements.


Most popular in 24h

MoreTop news


Back to top Links | About Us | Jobs | Contact Us | 申博手机APP版登入
Copyright ©1999-2020 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
菲律宾太阳网上娱乐登入 申博太阳娱乐评价登入 申博会员登入 申博138官网登入 菲律宾申博在线支付宝充值 申博管理网登入
菲律宾申博开户怎么样登入 太阳城申博代理加盟 菲律宾申博怎么注册登入 菲律宾申博在线赌场 菲律宾申博在线开户登入 申博在线私网代理登入
菲律宾申博官方网址 申博在线直营网登入 申博最新网址 菲律宾申博在线官网登入 菲律宾申博娱乐网 申博菲律宾太阳城88
申博游戏代理登入 申博官网开户 菲律宾申博在线登入官网 菲律宾官网 申博官网娱乐城 申博申请提款